Trial Condition(s):

Magnetic Resonance Imaging, Kidney Neoplasms

MRI study of 1.0 molar Gadobutrol and 0.5 molar Gd-DTPA with a single i.v. injection in patients with known or suspected renal lesions

Bayer Identifier:

90931

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
471
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Gadavist/Gadovist (Gadobutrol, BAY86-4875)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

Trial Design